Tao, Andrew J. http://orcid.org/0000-0003-1576-986X
Jiang, Jiewei http://orcid.org/0000-0001-5497-9371
Gadbois, Gillian E.
Goyal, Pavitra http://orcid.org/0009-0005-9219-2736
Boyle, Bridget T.
Mumby, Elizabeth J.
Myers, Samuel A. http://orcid.org/0000-0001-7636-0887
English, Justin G. http://orcid.org/0000-0002-1161-8928
Ferguson, Fleur M. http://orcid.org/0000-0003-4091-7617
Funding for this research was provided by:
See manuscript file
Article History
Received: 30 March 2023
Accepted: 12 November 2023
First Online: 4 December 2023
Competing interests
: A.J.T., J.J., J.G.E. and F.M.F. are inventors on a provisional patent application (63/394,145) relating to the invention of the BioTAC system and its use in characterizing small molecules jointly owned by the University of California San Diego, Dana-Farber Cancer Institute and University of Utah. F.M.F. is a scientific co-founder and equity holder in Proximity Therapeutics, an equity holder in Triana Biomedicines. Fleur Ferguson is or was recently a consultant or received speaking honoraria from Eli Lilly and Co., RA Capital, Tocris BioTechne, Janssen Pharmaceuticals, and Plexium Inc. The Ferguson lab receives or has received research funding from Ono Pharmaceutical Co. Ltd and Merck & Co. J.G.E. is a scientific co-founder, equity holder, and scientific advisory board (SAB) member in Evolution Bio. The English lab receives or has received research funding from Eli Lilly and Co. The remaining authors declare no competing interests.